Literature DB >> 15530966

Insights into the loss of muscle mass following B. jararacussu venom in mice.

Humberto Santo Neto1, Viviane Urbini Vomero, Maria Julia Marques.   

Abstract

Bothrops jararacussu snake venom produces myonecrosis and nerve degeneration. In this work, we investigated whether nerve lesions or impaired muscle regeneration contributed to the permanent loss of muscle mass, a long-term sequela of envenoming. The right soleus muscle of adult male mice was injected with B. jararacussu venom (80 microg) while the left muscle received only saline (control). The mice were killed after 2 and 3 months and the muscles were removed and processed for examination by transmission electron microscopy and light microscopy. The nerve fibers, Schwann cells and neuromuscular junctions had regenerated in venom-treated muscle. The total number of muscle fibers was significantly lower (p<0.05) than in the control (617+/-48 versus 1235+/-97, respectively; mean+/-SEM, n=10). These results show that the loss of muscle mass was most likely related to a decrease in the ability of the muscle to regenerate rather than to nerve lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530966     DOI: 10.1016/j.toxicon.2004.08.007

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  2 in total

1.  Photobiomodulation Protects and Promotes Differentiation of C2C12 Myoblast Cells Exposed to Snake Venom.

Authors:  Luciana Miato Gonçalves Silva; Camila Aparecida Alves da Silva; Aline da Silva; Rodolfo Paula Vieira; Raquel Agnelli Mesquita-Ferrari; José Carlos Cogo; Stella Regina Zamuner
Journal:  PLoS One       Date:  2016-04-08       Impact factor: 3.240

Review 2.  Why is Skeletal Muscle Regeneration Impaired after Myonecrosis Induced by Viperid Snake Venoms?

Authors:  José María Gutiérrez; Teresa Escalante; Rosario Hernández; Stefano Gastaldello; Patricia Saravia-Otten; Alexandra Rucavado
Journal:  Toxins (Basel)       Date:  2018-05-01       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.